Isolation and characterization of cyclo-(tryptophanyl-prolyl) and chloramphenicol from streptomyces sp. SUK 25 with antimethicillin-resistant staphylococcus aureus activity

Drug Design, Development and Therapy

Volumn 10, Issue , 2016, Pages 1817-1827

  Alshaibani, Muhanna M ^a   Jalil, Juriyati ^b   Sidik, Nik M ^b   Edrada Ebel, Ruangelie ^c   Zin, Noraziah M ^a  

^a Faculty of Health Science   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Chloramphenicol; Cyclo (tryptophanyl prolyl); HR MS; MRSA; NMR; SUK 25; Zingiber spectabile

Indexed keywords

2,2 DICHLORO N [2 HYDROXY 1 (HYDROXYMETHYL) 2 (4 NITROPHENYL) ETHYL] ACETAMIDE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CYCLO (TRYPTOPHANYL PROLYL); CYCLO (TRYPTOPHANYL PROLYL) 3 (1H INDOL 3YLMETHYL) HEXAHYDROPYRROLO [1,2 A] PYRAZINE 1,4 DIONE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CYCLO-(TRYPTOPHANYL-PROLYL); RNA 16S; TRYPTOPHAN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHEMOTAXONOMY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; GENE SEQUENCE; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHYLOGENY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHLORAMPHENICOL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RNA, RIBOSOMAL, 16S; TRYPTOPHAN;

EID: 84973495961     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S101212     Document Type: Article

References (73)

1. Ji HF, Li XJ, Zhang HY. Natural products and drug discovery. EMBO Rep. 2009;10(3):194-200
2. Pan L, Chai H-B, Kinghorn AD. Discovery of new anticancer agents from higher plants. Front Biosci. 2012;4:142
3. Tayung K, Sarkar M, Baruah P. Endophytic fungi occurring in Ipomoea carnea tissues and their antimicrobial potentials. Braz Arch Biol Technol. 2012;55(5):653-660
4. Strobel G, Daisy B. Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev. 2003;67(4):491-502
5. Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol. 2007;45(5):683-690
6. El-Ghorab AH, Nauman M, Anjum FM, Hussain S, Nadeem M. A comparative study on chemical composition and antioxidant activity of ginger (Zingiber officinale) and cumin (Cuminum cyminum). J Agric Food Chem. 2010;58(14):8231-8237
7. Kundu JK, Na H-K, Surh Y-J. Ginger-derived phenolic substances with cancer preventive and therapeutic potential. Forum Nutr. 2009; 61:182-192
8. Khalid MH, Akhtar MN, Mohamad AS, et al. Antinociceptive effect of the essential oil of Zingiber zerumbet in mice: possible mechanisms. J Ethnopharmacol. 2011;137(1):345-351
9. Lechevalier H, Lechevalier MP. Introduction to the order Actinomycetales. In: Starr MP, Stolp H, Trüper HG, Balows A, Schlegel HG, editors. The Prokaryotes. Vol. 2. Germany: Springer-Verlag Berlin; 1981:1915-1922
10. McCormick JR, Flärdh K. Signals and regulators that govern Streptomyces development. FEMS Microbiol Rev. 2012;36(1):206-231
11. Williams S, Goodfellow M, Alderson G, Wellington E, Sneath P, Sackin M. Numerical classification of Streptomyces and related genera. J Gen Microbiol. 1983;129(6):1743-1813
12. Gao B, Gupta RS. Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria. Microbiol Mol Biol Rev. 2012;76(1):66-112
13. Tanaka Y, Omura S. Agroactive compounds of microbial origin. Annu Rev Microbiol. 1993;47:57-87
14. Berdy J. Bioactive microbial metabolites. J Antibiot. 2005;58(1): 1-26
15. Weber T, Welzel K, Pelzer S, Vente A, Wohlleben W. Exploiting the genetic potential of polyketide producing streptomycetes. J Biotechnol. 2003;106(2):221-232
16. Zin N, Loi C, Sarmin N, Rosli A. Cultivation-dependent characterization of endophytic actinomycetes. Res J Microbiol. 2010;5(8):717-724
17. Junaidah AS, Suhaini S, Sidek HM, Basri DF, Zin NM. Anti-methicillin resistant Staphylococcus aureus activity and optimal culture condition of Streptomyces sp. SUK 25. Jundishapur J Microbiol. 2015;8(5): e16784
18. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616-687
19. Stapleton PD, Taylor PW. Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog. 2002;85(pt 1):57
20. Prasad C. Bioactive cyclic dipeptides. Peptides. 1995;16(1):151-164
21. Park YC, Gunasekera SP, Lopez JV, McCarthy PJ, Wright AE. Metabolites from the marine-derived fungus Chromocleista sp. isolated from a deep-water sediment sample collected in the Gulf of Mexico. J Nat Prod. 2006;69(4):580-584
22. Martins MB, Carvalho I. Diketopiperazines: biological activity and synthesis. Tetrahedron. 2007;63(40):9923-9932
23. Ahmed Z, Vining L. Evidence for a chromosomal location of the genes coding for chloramphenicol production in Streptomyces venezuelae. J Bacteriol. 1983;154(1):239-244
24. Thakur D, Bora T, Bordoloi G, Mazumdar S. Influence of nutrition and culturing conditions for optimum growth and antimicrobial metabolite production by Streptomyces sp. 201. J Med Mycol. 2009;19(3):161-167
25. Williston EH, Zia-Walrath P, Youmans GP. Plate methods for testing antibiotic activity of actinomycetes against virulent human type tubercle bacilli. J Bacteriol. 1947;54(5):563-568
26. Alexander M. Introduction to Soil Microbiology. Hoboken, NJ: John Wiley & Sons; 1977
27. Zin NM, Sarmin NI, Ghadin N, et al. Bioactive endophytic streptomycetes from the Malay Peninsula. FEMS Microbiol Lett. 2007;274(1):83-88
28. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA. Practical Streptomyces Genetics. Norwich: John Innes Foundation; 2000
29. Coombs JT, Franco CMM. Isolation and identification of actinobacteria from surface-sterilized wheat roots. Appl Environ Microbiol. 2003;69(9):5603-5608
30. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4(4):406-425
31. Staneck JL, Roberts GD. Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Appl Microbiol. 1974;28(2):226-231
32. CLSI (Clinical and Laboratory Standards Institute). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard. M07-A8. 8th ed. Wayne, PA: CLSI; 2011
33. Magiorakos AP, Srinivasan A, Carey R, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281
34. Birch A, Wright J. The brevianamides: a new class of fungal alkaloid. J Chem Soc D. 1969;12:644b-645b
35. Kobayashi D, Palumbo J. Bacterial endophytes and their effects on plants and uses in agriculture. In: Bacon CW, White JF, editors. Microbial Endophytes. New York, NY: Marcel Dekker, Inc.; 2000:199-233
36. Amar MB, Elleuch L, Abd-Alla HI, et al. The new Streptomyces sp. TN605 strain secretes simultaneously three active compounds and a high level of the interesting pharmaceutical industry intermediate: 2-hydroxyphenylacetic acid. Bull Environ Pharmacol Life Sci. 2012; 1:48-56
37. Morakchi H, Ayari A, Taok M, Kirane D, Cochet N. Characterization of Streptomyces strain SLO-105 isolated from Lake Oubeira sediments in North-East of Algeria. Afr J Biotechnol. 2009;8(22):6332-6336
38. Cho SS, Choi YH, Simkhada JR, Mander P, Park da J, Yoo JC. A newly isolated Streptomyces sp. CS392 producing three antimicrobial compounds. Bioprocess Biosyst Eng. 2012;35(1-2):247-254
39. Rajan BM, Kannabiran K. Extraction and identification of antibacterial secondary metabolites from marine Streptomyces sp. VITBRK2. Int J Mol Cell Med. 2014;3(3):130
40. Lee L-H, Zainal N, Azman A-S, et al. Streptomyces pluripotens sp. nov., a bacteriocin-producing streptomycete that inhibits meticillinresistant Staphylococcus aureus. Int J Syst Evol Microbiol. 2014; 64(pt 9):3297-3306
41. Khieu T-N, Liu M-J, Nimaichand S, et al. Characterization and evaluation of antimicrobial and cytotoxic effects of Streptomyces sp. HUST012 isolated from medicinal plant Dracaena cochinchinensis Lour. Front Microbiol. 2015;6:574
42. Okami Y. Studies on the characters of antibiotic Streptomyces I. on the characters of a chloromycetin-producing strain (O-163). Jpn Med J. 1948; 1(6):499-503
43. Lechevalier MP, Lechevalier H. Chemical composition as a criterion in the classification of aerobic actinomycetes. Int J Syst Bacteriol. 1970; 20(4):435-443
44. Junaidah AS, Lian HH, Basri DF, Zin NM. Mode of action of endophytic Streptomyces sp., SUK 25 extracts against MRSA; microscopic, biochemical and time-kill analysis. Int J Pharm Sci Rev Res. 2014; 30(1):11-17
45. Mahmoud MAS. Bioactive secondary metabolites from marine and terrestrial bacteria: isoquinolinequinones, bacterial compounds with a novel pharmacophor, PhD Thesis, Göttingen University, 2005
46. Gloer JB. The chemistry of fungal antagonism and defense. Can J Botany. 1995;73(S1):1265-1274
47. Shiomi K, Omura S. Antiparasitic agents produced by microorganisms. Proc Jpn Acad Ser B. 2004;80(6):245-258
48. Rand TG, Giles S, Flemming J, Miller JD, Puniani E. Inflammatory and cytotoxic responses in mouse lungs exposed to purified toxins from building isolated Penicillium brevicompactum Dierckx and P. chrysogenum Thom. Toxicol Sci. 2005;87(1):213-222
49. Graz M, Hunt A, Jamie H, Grant G, Milne P. Antimicrobial activity of selected cyclic dipeptides. Pharmazie. 1999;54(10):772-775
50. Kumar SN, Mohandas C, Nambisan B. Purification, structural elucidation and bioactivity of tryptophan containing diketopiperazines, from Comamonas testosteroni associated with a rhabditid entomopathogenic nematode against major human-pathogenic bacteria. Peptides. 2014;53: 48-58
51. Ben Ameur Mehdi R, Shaaban KA, Rebai IK, Smaoui S, Bejar S, Mellouli L. Five naturally bioactive molecules including two rhamnopyranoside derivatives isolated from the Streptomyces sp. strain TN58. Nat Prod Res. 2009;23(12):1095-1107
52. Zhang X-Y, Xu X-Y, Peng J, et al. Antifouling potentials of eight deep-sea-derived fungi from the South China Sea. J Ind Microbiol Biotechnol. 2014;41(4):741-748
53. Pfenning A, Turnipseed S, Roybal J, et al. Confirmation of chloramphenicol residues in crawfish by electrospray LC/MS. US FDA Laboratory Information Bulletin No. 2002;4289(18):8
54. Gantverg A, Shishani I, Hoffman M. Determination of chloramphenicol in animal tissues and urine: liquid chromatography-tandem mass spectrometry versus gas chromatography-mass spectrometry. Anal Chim Acta. 2003;483(1):125-135
55. Ehrlich J, Bartz QR, Smith RM, Joslyn DA, Burkholder PR. Chloromycetin, a new antibiotic from a soil actinomycete. Science. 1947; 106(2757):417-417
56. Smith RM, Joslyn DA, Gruhzit OM, McLean IW Jr., Penner MA, Ehrlich J. Chloromycetin: biological studies. J Bacteriol. 1948;55(3):425
57. Umezawa H, Tazaki T, Okami Y, Fukuyama S. On the new source of chloromycetin, Streptomyces omiyaensis. Jpn Med J. 1949;2(4): 207-211
58. Tamura A, Takeda I, Naruto S, Yoshimura Y. Chloramphenicol from Streptosporangium viridogriseum var. kofuense. J Antibiot. 1971; 24(4):270-270
59. Mosher RH, Camp DJ, Yang K, Brown MP, Shaw WV, Vining LC. Inactivation of chloramphenicol by o-phosphorylation a novel resistance mechanism in Streptomyces venezuelae isp5230, a chloramphenicol producer. J Biol Chem. 1995;270(45):27000-27006
60. Aouiche A, Sabaou N, Meklat A, et al. Saccharothrix sp. PAL54, a new chloramphenicol-producing strain isolated from a Saharan soil. World J Microbiol Biotechnol. 2012;28(3):943-951
61. Seth S. Textbook of pharmacology. Indian J Pharmacol. 1998; 30(1):58
62. McKee E, Ferguson M, Bentley A, Marks T. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother. 2006;50(6):2042-2049
63. Kirk RW, Osborne C, Murtaugh R. Kirk’s Current Veterinary Therapy XII. Small Animal Practice. Philadelphia, PA: WB Saunders Company; 1995
64. Plumb D. Veterinary Drug Handbook. 4th ed. White Bear Lake, MN: Pharma Vet Publishing; 1991
65. EFSA. Scientific opinion on chloramphenicol in food and feed. EFSA J. 2014;12(11): 3145-3907
66. Yaffe SJ, Aranda JV. Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2010
67. White NJ. Salmonella typhi (typhoid fever) and S. paratyphi (paratyphoid fever). Antimicrob Ther Vaccine. 2002. Available from http://www.antimicrobe.org/b106.asp. Accessed December 23, 2015
68. Woodward TE, Smadel JE. Management of typhoid fever and its complications. Ann Intern Med. 1964;60(1):144-157
69. Fayyaz M, Mirza IA, Ahmed Z, Abbasi SA, Hussain A, Ali S. In vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus. J Coll Physicians Surg Pak. 2013;23(9):637-640
70. French G. Bactericidal agents in the treatment of MRSA infections the potential role of daptomycin. J Antimicrob Chemother. 2006;58(6): 1107-1117
71. Berche P, Gaillard JL, Simonet M. Bactériologie: Bactéries des Infections Humaines. [Nosocomial Infections Caused by Bacteria and Their Prevention in Bacteriology]. Paris: Flammarion Médecine-Sciences; 1988
72. Konaté K, Mavoungou JF, Lepengué AN, et al. Antibacterial activity against β-lactamase producing methicillin and ampicillin-resistants Staphylococcus aureus: fractional inhibitory concentration index (FICI) determination. Ann Clin Microbiol Antimicrob. 2012;11(1):18
73. Cha JO, Park YK, Lee YS, Chung GT. In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea. Diagn Microbiol Infect Dis. 2011; 70(1):112-118